Oncolytics Biotech
ONCY
$1.19
Share price
0.85%
Change (1 day)
-30.41%
Change (1 year)
Categories
EPS for Oncolytics Biotech (ONCY)
EPS in 2023 (TTM): -$0.33
According to Oncolytics Biotech 's latest financial reports the company's current EPS (TTM) is -$0.33. In 2022 the company made an earnings per share (EPS) of -$0.34 an increase over its 2021 EPS that were of -$0.39.
EPS history for Oncolytics Biotech from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.33 | -0.44% |
| 2022 | -$0.34 | -13.63% |
| 2021 | -$0.39 | -5.18% |
| 2020 | -$0.41 | -64.61% |
| 2019 | -$1.16 | 43.39% |
| 2018 | -$0.81 | -7.73% |
| 2017 | -$0.87 | -3.95% |
| 2016 | -$0.91 | 3.91% |
| 2015 | -$0.88 | -48.87% |
| 2014 | -$1.71 | -33.01% |
| 2013 | -$2.56 | -42.77% |
| 2012 | -$4.47 | 15.19% |
| 2011 | -$3.88 | 6.95% |
| 2010 | -$3.63 | 31.48% |
| 2009 | -$2.76 | -25.46% |
| 2008 | -$3.70 | -31.96% |
| 2007 | -$5.44 | -297.48% |
| 2006 | $2.76 | -0.74% |
| 2005 | $2.78 | -193.48% |
| 2004 | -$2.97 | -243.05% |
| 2003 | $2.08 | 57.79% |
| 2002 | $1.32 | -15.01% |
| 2001 | $1.55 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $5.43 | -1,726.00% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | -1,288.96% | 🇺🇸 USA |
 Mirati Therapeutics MRTX | -$12.82 | 3,739.43% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | -$4.66 | 1,295.61% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -$2.00 | 498.97% | 🇮🇱 Israel |
 AVEO Oncology
AVEO | -$0.84 | 151.57% | 🇺🇸 USA |